Five preventable causes of kidney graft loss in the 1990s: a single-center analysis.
暂无分享,去创建一个
D. Dunn | A. Matas | J. Najarian | R. Kandaswamy | D. Sutherland | R. Gruessner | A. Humar | W. Payne | K. Gillingham
[1] K. Rootwelt,et al. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. , 2001, Transplantation.
[2] F. Delmonico,et al. Transplant Kidneys Sooner: Discard Fewer Kidneys , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] M. Skeans,et al. The natural history of azathioprine compliance after renal transplantation. , 2001, Kidney international.
[4] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[5] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[6] Michael Green. Management of Epstein–Barr Virus‐induced Post‐transplant Lymphoproliferative Disease in Recipients of Solid Organ Transplantation , 2001, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] A. Åsberg,et al. Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] A. Matas,et al. Peri‐operative cardiac morbidity in kidney transplant recipients: incidence and risk factors , 2001, Clinical transplantation.
[9] M. Mitsnefes,et al. Short‐term pediatric renal transplant survival: Blood pressure and allograft function , 2001, Pediatric transplantation.
[10] D. Gjertson,et al. Clinical impact of delayed graft function for kidney transplantation , 2001 .
[11] M. Joffe,et al. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. , 2001, The New England journal of medicine.
[12] G. Appel,et al. Antiphospholipid antibody syndrome and renal disease , 2001, Current opinion in nephrology and hypertension.
[13] R. Wolfe,et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. , 2001, Journal of the American Society of Nephrology : JASN.
[14] A. Sánchez-Fructuoso,et al. DOES RENAL MASS EXERT AN INDEPENDENT EFFECT ON THE DETERMINANTS OF ANTIGEN-DEPENDENT INJURY? , 2001, Transplantation.
[15] F. Port,et al. Effect of waiting time on renal transplant outcome. , 2000, Kidney international.
[16] A. Matas,et al. PRE-EMPTIVE TRANSPLANTS FOR PATIENTS WITH RENAL FAILURE: An Argument Against Waiting Until Dialysis , 2000, Transplantation.
[17] R. Elashoff,et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.
[18] D. Churchill,et al. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada. , 2000, Journal of the American Society of Nephrology : JASN.
[19] B. Dahlbäck,et al. Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection. , 2000, Transplantation.
[20] P. Kimball,et al. Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study. , 2000, Transplantation.
[21] S. Hariharan,et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. , 2000, The New England journal of medicine.
[22] A. Matas,et al. Immunologic factors: the major risk for decreased long-term renal allograft survival. , 1999, Transplantation.
[23] R. Wolfe,et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. , 1999, The New England journal of medicine.
[24] J. Stone,et al. Antiphospholipid antibody syndrome in renal transplantation: occurrence of clinical events in 96 consecutive patients with systemic lupus erythematosus. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[25] A. Irish,et al. Renal allograft thrombosis: can thrombophilia explain the inexplicable? , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[26] D. Dunn,et al. Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. , 1999, Annals of surgery.
[27] B. Tönshoff,et al. Heterozygous prothrombin gene mutation: a new risk factor for early renal allograft thrombosis. , 1999, Transplantation.
[28] F. Cosio,et al. Patient survival after renal transplantation: II. The impact of smoking , 1999, Clinical transplantation.
[29] J. Mcintyre,et al. Antiphospholipid antibodies are a risk factor for early renal allograft failure. , 1999, Transplantation.
[30] R. Gaston,et al. Late renal allograft loss: noncompliance masquerading as chronic rejection. , 1999, Transplantation proceedings.
[31] H. Geiger,et al. Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant recipients. , 1999, Clinical nephrology.
[32] R. Wolfe,et al. Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients. , 1999, Kidney international.
[33] A. Tosetto,et al. Activated Protein C Resistance and Factor V Leiden Mutation Are Independent Risk Factors for Venous Thromboembolism , 1999, Annals of Internal Medicine.
[34] A. Matas. Noncompliance and late graft loss: Implications for long-term clinical studies , 1999 .
[35] P. Nickerson,et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. , 1998, Journal of the American Society of Nephrology : JASN.
[36] M. Pfeffer,et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[37] G. Remuzzi,et al. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial , 1998, The Lancet.
[38] A. Matas. Risk factors for chronic rejection--a clinical perspective. , 1998, Transplant immunology.
[39] F. Cosio,et al. Patient survival after renal transplantation: I. The impact of dialysis pre-transplant , 1998 .
[40] B. Brenner,et al. Antigen-independent determinants of graft survival in living-related kidney transplantation. , 1997, Kidney international. Supplement.
[41] A. Matas,et al. Effect of initial slow graft function on renal allograft rejection and survival. , 1997, Clinical transplantation.
[42] A. Matas,et al. Effect of early cyclosporine levels on kidney allograft rejection. , 1997, Clinical transplantation.
[43] P. Morris,et al. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. , 1997, Transplantation.
[44] E. Racadot,et al. Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients. , 1997, Transplantation.
[45] R. Wolfe,et al. Delayed graft function: risk factors and implications for renal allograft survival. , 1997, Transplantation.
[46] B. Brenner,et al. Antigen-independent determinants of cadaveric kidney transplant failure. , 1996, JAMA.
[47] B. Chavers,et al. The importance of early cyclosporine levels in pediatric kidney transplantation. , 1996, Clinical transplantation.
[48] F. Locatelli,et al. Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .
[49] D. Rush,et al. Effect of subclinical rejection on renal allograft histology and function at 6 months. , 1996, Transplantation proceedings.
[50] H. Hricak. Imaging of the genitourinary system. , 1995, Academic radiology.
[51] A. Matas,et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. , 1995, Transplantation.
[52] K. Byth,et al. Renal graft thrombosis. A survey of 134 consecutive cases. , 1994, Transplantation.
[53] D. Gjertson,et al. The hyperfiltration hypothesis in human renal transplantation. , 1994, Transplantation.
[54] G. Appel,et al. Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[55] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[56] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[57] G. Mayer,et al. THE EFFECTS OF LISINOPRIL ON RENAL FUNCTION IN PROTEINURIC RENAL TRANSPLANT RECIPIENTS , 1993, Transplantation.
[58] D. Dunn,et al. Early versus late acute renal allograft rejection: impact on chronic rejection. , 1993 .
[59] D. Dunn,et al. Risk factors for chronic rejection in renal allograft recipients. , 1993, Transplantation.
[60] R. Wilson,et al. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. , 1992, Archives of internal medicine.
[61] R. Wilson,et al. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure , 1992, The Lancet.
[62] B. Brenner,et al. In renal transplantation, one size may not fit all. , 1992, Journal of the American Society of Nephrology : JASN.
[63] D. Dunn,et al. Causes of Renal Allograft Loss: Progress in the 1980s, Challenges for the 1990s , 1991, Annals of surgery.
[64] R. Wolfe,et al. Long-term survival in renal transplant recipients with graft function. , 2000, Kidney international.
[65] X. Lens,et al. Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[66] D. Dunn,et al. 5,000 kidney transplants--a single-center experience. , 2000, Clinical transplants.
[67] Cecka Jm. The UNOS Scientific Renal Transplant Registry. , 1999 .
[68] G. Opelz,et al. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. , 1998, Kidney international.
[69] D. Gjertson. The role of death in kidney graft failure. , 1998, Clinical transplants.
[70] R. Ploeg,et al. Primary renal graft thrombosis. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.